Cameco Corp (CCJ) concluded trading on Wednesday at a closing price of $41.97, with 4.55 million shares of worth about $190.83 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -27.66% during that period and on April 23, 2025 the price saw a gain of about 4.45%. Currently the company’s common shares owned by public are about 435.31M shares, out of which, 433.74M shares are available for trading.
Stock saw a price change of 2.84% in past 5 days and over the past one month there was a price change of -8.24%. Year-to-date (YTD), CCJ shares are showing a performance of -18.33% which decreased to -12.74% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $35.00 but also hit the highest price of $62.55 during that period. The average intraday trading volume for Cameco Corp shares is 4.44 million. The stock is currently trading 3.42% above its 20-day simple moving average (SMA20), while that difference is down -1.96% for SMA50 and it goes to -12.04% lower than SMA200.
Cameco Corp (NYSE: CCJ) currently have 435.31M outstanding shares and institutions hold larger chunk of about 76.57% of that.
The stock has a current market capitalization of $18.27B and its 3Y-monthly beta is at 0.89. PE ratio of stock for trailing 12 months is 148.09, while it has posted earnings per share of $0.28 in the same period. Its PEG reads 2.67 and has Quick Ratio of 0.92 while making debt-to-equity ratio of 0.20. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CCJ, volatility over the week remained 3.51% while standing at 5.22% over the month.
Stock’s fiscal year EPS is expected to rise by 87.96% while it is estimated to increase by 75.37% in next year. EPS is likely to grow at an annualized rate of 55.45% for next 5-years, compared to annual growth of 15.41% made by the stock over the past 5-years.
Coverage by Bernstein stated Cameco Corp (CCJ) stock as an Outperform in their note to investors on April 01, 2025, suggesting a price target of $52 for the stock. Stock get a Buy rating from Goldman on April 01, 2024.
